LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

Home・Akcijų sąrašas・Avita Therapeutics Inc

Avita Therapeutics Inc

Uždarymo kaina

3.48 -1.69

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

3.4699999999999998

Max

3.51

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-3.3M -13M
Pardavimai	-1.4M 17M
Pelnas, tenkantis vienai akcijai	-0.712
Pelno marža	-77.289
Darbuotojai	260
EBITDA	4M -8.1M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+85.71% upside

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-12M 109M
Ankstesnė atidarymo kaina	5.17
Ankstesnė uždarymo kaina	3.48

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

8.83 / 9.77 Palaikymas ir pasipriešinimas

Avita Therapeutics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-07 23:00; UTC

Įsigijimai, susijungimai, perėmimai

Brookfield, GIC Agree $4.5 Billion Deal for Australia's National Storage -- Update

2025-12-05 21:08; UTC

Įsigijimai, susijungimai, perėmimai

Meta Platforms Buys AI-Device Maker Limitless

2025-12-05 19:39; UTC

Pagrindinės rinkos jėgos

Parsons' FAA Bid Loss Clouds Outlook After Rocky Year for Contractors

2025-12-05 19:17; UTC

Įsigijimai, susijungimai, perėmimai

Constellation Energy Agrees to Divest Assets to Finalize Calpine Deal

2025-12-07 23:42; UTC

Rinkos pokalbiai

Nikkei May Rise on Weaker Yen -- Market Talk

2025-12-07 23:05; UTC

Rinkos pokalbiai

RBA Set to Remain 'Emphatically' On Hold, Westpac Says -- Market Talk

2025-12-07 22:18; UTC

Rinkos pokalbiai

RBA Set To Conclude Year With Hawkish Message -- Market Talk

2025-12-06 16:52; UTC

Įsigijimai, susijungimai, perėmimai

As Netflix Swoops In to Buy Warner Bros., We Revisit the Studio's Long, Twisted Journey -- Barrons.com

2025-12-06 10:30; UTC

Įsigijimai, susijungimai, perėmimai

Why Netflix Shareholders Aren't Thrilled to Acquire Warner Bros. -- Heard on the Street -- WSJ

2025-12-06 02:38; UTC

Įsigijimai, susijungimai, perėmimai

How a Netflix-Warner Deal Would Change Everything in Hollywood -- Again -- WSJ

2025-12-05 21:59; UTC

Įsigijimai, susijungimai, perėmimai

Netflix's Megadeal Will Need the Trump Administration's Blessing -- Update

2025-12-05 21:50; UTC

Rinkos pokalbiai

Uždarbis

Financial Services Roundup: Market Talk

2025-12-05 21:50; UTC

Įsigijimai, susijungimai, perėmimai

The Netflix and Warner Bros. Deal Is Far From a Sure Thing -- Barrons.com

2025-12-05 21:36; UTC

Rinkos pokalbiai

Return of Shipping to Red Sea a Step Closer, Xeneta Says -- Market Talk

2025-12-05 21:35; UTC

Įsigijimai, susijungimai, perėmimai

The Netflix-Warner Bros. Deal Has a Wildcard. How Paramount Could Still Win. -- Barrons.com

2025-12-05 21:26; UTC

Įsigijimai, susijungimai, perėmimai

Warner Bros. Discovery and Netflix Enter Exclusive Deal Negotiations -- 7th Update

2025-12-05 21:12; UTC

Rinkos pokalbiai

Natural Gas Surge 9% This Week on Strong Flow of Exports -- Market Talk

2025-12-05 21:03; UTC

Rinkos pokalbiai

Uždarbis

Bank of Montreal Logs Solid Quarter, Though Some Unease Remains -- Market Talk

2025-12-05 21:01; UTC

Rinkos pokalbiai

Oil Caps Positive Week on Geopolitical Turmoil -- Market Talk

2025-12-05 20:43; UTC

Įsigijimai, susijungimai, perėmimai

Limitless CEO Siroker: Will No Longer Sell Pendant to New Customers

2025-12-05 20:43; UTC

Įsigijimai, susijungimai, perėmimai

Limitless CEO Siroker: Existing Pendant Customers to Be Supported for at Least Another Year

2025-12-05 20:42; UTC

Įsigijimai, susijungimai, perėmimai

Limitless CEO Dan Siroker: Limitless Has Been Acquired by Meta >META

2025-12-05 20:01; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Landed a Big Deal. Now it Could Have a Big Fight. -- WSJ

2025-12-05 19:44; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-12-05 19:44; UTC

Rinkos pokalbiai

Canada Dollar Gains Nearly 1% on Jobs Data, Rate Outlook -- Market Talk

2025-12-05 19:39; UTC

Rinkos pokalbiai

Silver Climbs to a New Record High -- Market Talk

2025-12-05 19:31; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Stock Falls. Wall Street Is Worried About Warner Deal's High Price and Debt. -- Barrons.com

2025-12-05 18:30; UTC

Rinkos pokalbiai

Canada Jobless Rate Can Fall More Before Labor Slack Disappears -- Market Talk

2025-12-05 18:28; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Stock Falls. Wall Street Is Worried About Warner Deal's High Price and Debt. -- Barrons.com

2025-12-05 18:24; UTC

Įsigijimai, susijungimai, perėmimai

AMC and IMAX Stocks Drop. Roku Rises. How the Netflix-Warner Bros. Deal Could Shake Up Entertainment. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Avita Therapeutics Inc Prognozė

Kainos tikslas

By TipRanks

85.71% į viršų

12 mėnesių prognozė

Vidutinis 6.5 USD 85.71%

Aukščiausias 11 USD

Žemiausias 3 USD

Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Avita Therapeutics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

4 ratings

Pirkti

Laikyti

Parduoti

Remiantis 4 analitikų, pateikusių Avita Therapeutics Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

8.83 / 9.77Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.